Imagine plant-based meat alternatives that offer the texture, flavour, and appearance of animal proteins. Using innovations in extrusion processing, we develop new protein texturizing technologies that create plant-based products that mimic the texture of animal proteins. The texture of plant-based protein products still poses a barrier to convincing consumers to adopt alternatives to meat. But current approaches to creating plant-based meat substitutes are falling short in building a protein structure that mirrors a meaty texture experience. We help plant-based protein producers satisfy consumers’ desire for meaty texture and appearance. By improving texture, our techniques enhance the eating experience of plant-based products. The result: a more convincing and satisfying alternative to replace animal-based foods.
Imagine plant-based meat alternatives that offer the texture, flavour, and appearance of animal proteins. Using innovations in extrusion processing, we develop new protein texturizing technologies that create plant-based products that mimic the texture of animal proteins. The texture of plant-based protein products still poses a barrier to convincing consumers to adopt alternatives to meat. But current approaches to creating plant-based meat substitutes are falling short in building a protein structure that mirrors a meaty texture experience. We help plant-based protein producers satisfy consumers’ desire for meaty texture and appearance. By improving texture, our techniques enhance the eating experience of plant-based products. The result: a more convincing and satisfying alternative to replace animal-based foods.
Fine Data Lab is a digital data analysis company offering digital marketing consulting, analytics, and data analytics solutions.
Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications in an effort to eliminate the inherent subjectivity of cervical exams. Its Gynescope is a patented imaging colposcope that delivers 15-micron image resolution over a wide field of view and a range of working distances. The Gynescope also has multispectral illumination options, allowing early detection of cervical cancer while meaningfully reducing misdiagnoses. The Gynescope enables sophisticated imaging with simultaneous complex interventional procedures to support the best clinical outcomes.
OP.GG creates profiles for gamers by analyzing game data from the games they play. Through these profiles, gamers can improve their gameplay and see the game performance of their opponents and friends. Currently OP.GG has services for League of Legends, Overwatch and PUBG with over 28 million monthly users from around the world.
UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. UltraSight won the TCT 2020 Innovation Competition which took place during the Transcatheter Cardiovascular Therapeutics world conference. For mor information please visit us at www.ultrasight.com
Todos Medical Ltd is an in vitro diagnostics company based in Rehovot, HaMerkaz, founded in 2009. The company specializes in testing solutions for breast cancer, Alzheimer's disease, and COVID-19. Its team comprises experts from various fields, including medicine, physics, biochemistry, digital signal processing, and electrical engineering, which contributes to its competitive edge in the market. Todos Medical generates all its revenue from the United States, focusing on innovative diagnostic approaches to improve patient outcomes.
Nanox Vision is a healthcare technology company that specializes in advanced medical imaging solutions. Incorporated in 2011 and based in Gibraltar, the company has developed the Nanox System, which provides Medical Screening as a Service (MSaaS) aimed at preventative healthcare. This system is built on proprietary cold cathode technology, originally derived from innovations in high-definition flat panel displays. After over two decades of research and development and substantial financial investment, Nanox has created a unique imaging platform that enhances X-ray capabilities. Central to this technology is a nano-scale chip developed using specialized nanofabrication techniques, which allows for increased power density and uniformity in imaging. The Nanox System is designed to support diverse applications in medical imaging and is complemented by additional peripheral technologies to maximize its real-world utility.
UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. UltraSight won the TCT 2020 Innovation Competition which took place during the Transcatheter Cardiovascular Therapeutics world conference. For mor information please visit us at www.ultrasight.com
BiSiChem is a biotechnology company that focuses on the drug discovery and development field.
NextNine is a leader in Operational Technology (OT) security management software for industrial and critical infrastructure, markets that are vulnerable to cyber security attacks and are underserved by conventional enterprise IT solutions. Using NextNine you can have centralized OT security management for your entire SCADA/ICS environment. Distributed critical infrastructure plants and facilities with proprietary ICS/SCADA networks and devices, paired with the need for external vendors to provide remote maintenance and support, create an ideal target profile for hackers and terrorist attacks. Traditional IT security management solutions were designed to manage standard computing environments and cannot handle the proprietary processes, networks and devices of the ICS/SCADA world. In contrast, NextNine has over 10 years of leadership in OT security, and has purpose-built its product to deal with these unique challenges. NextNine’s solution is an industrial strength software platform delivering robust, customizable and field proven OT security management. Top tier critical infrastructure companies along with 5 of the 7 largest industrial vendors have standardized on NextNine. Today, the company has 6000 installations globally in fields such as oil, gas, mining, chemicals, energy, manufacturing, defense and critical infrastructure. NextNine has been recognized by the White House for its leadership in the efforts to improve critical infrastructure cyber security. NextNine has received ISO/IEC 27001:2013 certification, assuring NextNine's employees operate a comprehensive security program and manage information security risks effectively. NextNine's certificate is issued by the Standards Institution of Israel. The company was founded in 1998, is privately held and headquartered in New York.
Kailight Photonics develops optical modules for the telecommunications industry. It offers tunable optical signal regenerator, an optical component that operates with regenerators, optical switches, add/drop multiplexers, and cross-connects. The company's optical transmission, signal regeneration, and wavelength conversion technology provides optical-networking solutions for systems vendors. It provides its products to long-haul network market segments. The company, formerly known as Chilight Technologies, was founded in 2000 and is headquartered in Rehovot, Israel with an additional office in Dallas, Texas. As of May 15, 2007, Kailight Photonics, Inc. operates as a subsidiary of Optium Corporation.
CogniTens, Ltd. provides three dimensional optical measurement solutions for measuring sheet metal parts and assemblies. Its products include Optigo, a portable dimensional measurement platform operated by shop floor operators and engineers; and OptiCell, an automated 3D optical measurement system designed for supporting off-line recurring measurements of parts and assemblies in the production shop floor environment. The company also provides software products comprising CoreView Plan for planning, defining, and preparing comprehensive dimensional measurement programs for execution by Optigo and OptiCell dimensional measurement platforms; and CoreView Pro for viewing, analyzing, and reporting dimensional measurement information based on common dimensional measurement information generated by Optigo and OptiCell dimensional measurement platforms. In addition, it offers software products, including CoreView Lite for viewing measurement results produced by Optigo and OptiCell; off line measurement for off-line computation of collected dimensional data, analysis of results, and generation of CoreView files and other standard outputs; and Dimensional Domain Server that interfaces with a range of CogniTens platforms and software products to help in collecting, storing, and managing dimensional information generated across the organization. Its solutions support industrial engineering activities, such as tooling, part production, assembly, quality, and process control. The company serves automotive original equipment manufacturers, tier1 suppliers, tool and die companies, and other engineering and manufacturing organizations. It offers its products through distributors. The company was founded in 1995 and is based in Ramat Hasharon, Israel with additional offices in North America, South America, Europe, and Asia. As of September 3, 2007, CogniTens, Ltd. operates as a subsidiary of Hexagon Metrology AB.
Predix is a drug discovery and development company that uses a novel 3D Discovery and Optimization Engine for GPCR drug candidates and is taking its novel compounds into the clinic. The discovery engine uses a sophisticated proprietary algorithm, PREDICT(TM), for computer modeling the 3D structure of any GPCR target; advanced technologies HYPERION(TM) and RISS(TM) for rapid high-throughput in silico screening of millions of compounds against the 3D in silico model of the target; and an integrated medicinal/computational platform for lead optimization based on the receptor's structure (ICELR-3D(TM)) and predictive algorithms for important drug properties. In August, Predix and Physiome Sciences Inc. combined companies and expanded the expertise into ion channel drug discovery.
NextNine is a leader in Operational Technology (OT) security management software for industrial and critical infrastructure, markets that are vulnerable to cyber security attacks and are underserved by conventional enterprise IT solutions. Using NextNine you can have centralized OT security management for your entire SCADA/ICS environment. Distributed critical infrastructure plants and facilities with proprietary ICS/SCADA networks and devices, paired with the need for external vendors to provide remote maintenance and support, create an ideal target profile for hackers and terrorist attacks. Traditional IT security management solutions were designed to manage standard computing environments and cannot handle the proprietary processes, networks and devices of the ICS/SCADA world. In contrast, NextNine has over 10 years of leadership in OT security, and has purpose-built its product to deal with these unique challenges. NextNine’s solution is an industrial strength software platform delivering robust, customizable and field proven OT security management. Top tier critical infrastructure companies along with 5 of the 7 largest industrial vendors have standardized on NextNine. Today, the company has 6000 installations globally in fields such as oil, gas, mining, chemicals, energy, manufacturing, defense and critical infrastructure. NextNine has been recognized by the White House for its leadership in the efforts to improve critical infrastructure cyber security. NextNine has received ISO/IEC 27001:2013 certification, assuring NextNine's employees operate a comprehensive security program and manage information security risks effectively. NextNine's certificate is issued by the Standards Institution of Israel. The company was founded in 1998, is privately held and headquartered in New York.
CogniTens, Ltd. provides three dimensional optical measurement solutions for measuring sheet metal parts and assemblies. Its products include Optigo, a portable dimensional measurement platform operated by shop floor operators and engineers; and OptiCell, an automated 3D optical measurement system designed for supporting off-line recurring measurements of parts and assemblies in the production shop floor environment. The company also provides software products comprising CoreView Plan for planning, defining, and preparing comprehensive dimensional measurement programs for execution by Optigo and OptiCell dimensional measurement platforms; and CoreView Pro for viewing, analyzing, and reporting dimensional measurement information based on common dimensional measurement information generated by Optigo and OptiCell dimensional measurement platforms. In addition, it offers software products, including CoreView Lite for viewing measurement results produced by Optigo and OptiCell; off line measurement for off-line computation of collected dimensional data, analysis of results, and generation of CoreView files and other standard outputs; and Dimensional Domain Server that interfaces with a range of CogniTens platforms and software products to help in collecting, storing, and managing dimensional information generated across the organization. Its solutions support industrial engineering activities, such as tooling, part production, assembly, quality, and process control. The company serves automotive original equipment manufacturers, tier1 suppliers, tool and die companies, and other engineering and manufacturing organizations. It offers its products through distributors. The company was founded in 1995 and is based in Ramat Hasharon, Israel with additional offices in North America, South America, Europe, and Asia. As of September 3, 2007, CogniTens, Ltd. operates as a subsidiary of Hexagon Metrology AB.
Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.
Predix is a drug discovery and development company that uses a novel 3D Discovery and Optimization Engine for GPCR drug candidates and is taking its novel compounds into the clinic. The discovery engine uses a sophisticated proprietary algorithm, PREDICT(TM), for computer modeling the 3D structure of any GPCR target; advanced technologies HYPERION(TM) and RISS(TM) for rapid high-throughput in silico screening of millions of compounds against the 3D in silico model of the target; and an integrated medicinal/computational platform for lead optimization based on the receptor's structure (ICELR-3D(TM)) and predictive algorithms for important drug properties. In August, Predix and Physiome Sciences Inc. combined companies and expanded the expertise into ion channel drug discovery.
HyWire deals with the need for speed and capacity over the Internet. The demand for bandwidth is increasing exponentially mainly due to the number of users and the network applications (video, voice over IP, e-commerce and various enterprise applications).
NextNine is a leader in Operational Technology (OT) security management software for industrial and critical infrastructure, markets that are vulnerable to cyber security attacks and are underserved by conventional enterprise IT solutions. Using NextNine you can have centralized OT security management for your entire SCADA/ICS environment. Distributed critical infrastructure plants and facilities with proprietary ICS/SCADA networks and devices, paired with the need for external vendors to provide remote maintenance and support, create an ideal target profile for hackers and terrorist attacks. Traditional IT security management solutions were designed to manage standard computing environments and cannot handle the proprietary processes, networks and devices of the ICS/SCADA world. In contrast, NextNine has over 10 years of leadership in OT security, and has purpose-built its product to deal with these unique challenges. NextNine’s solution is an industrial strength software platform delivering robust, customizable and field proven OT security management. Top tier critical infrastructure companies along with 5 of the 7 largest industrial vendors have standardized on NextNine. Today, the company has 6000 installations globally in fields such as oil, gas, mining, chemicals, energy, manufacturing, defense and critical infrastructure. NextNine has been recognized by the White House for its leadership in the efforts to improve critical infrastructure cyber security. NextNine has received ISO/IEC 27001:2013 certification, assuring NextNine's employees operate a comprehensive security program and manage information security risks effectively. NextNine's certificate is issued by the Standards Institution of Israel. The company was founded in 1998, is privately held and headquartered in New York.
Predix is a drug discovery and development company that uses a novel 3D Discovery and Optimization Engine for GPCR drug candidates and is taking its novel compounds into the clinic. The discovery engine uses a sophisticated proprietary algorithm, PREDICT(TM), for computer modeling the 3D structure of any GPCR target; advanced technologies HYPERION(TM) and RISS(TM) for rapid high-throughput in silico screening of millions of compounds against the 3D in silico model of the target; and an integrated medicinal/computational platform for lead optimization based on the receptor's structure (ICELR-3D(TM)) and predictive algorithms for important drug properties. In August, Predix and Physiome Sciences Inc. combined companies and expanded the expertise into ion channel drug discovery.
Globecom Interactive Ltd. is a pioneering developer of enterprise, end-to-end broadband solutions for the creation, management, and delivery of rich dynamic media over multiple platforms. They provide software solutions enabling businesses to maximize the productivity of new and established Internet market channels.
Compugen Ltd. is a clinical-stage therapeutic discovery and development company headquartered in Holon, Israel. The company focuses on immuno-oncology, leveraging its unique computational discovery capabilities to identify novel drug targets and biological pathways for cancer therapeutics. Compugen's immuno-oncology pipeline includes several clinical-stage programs, such as COM701, an anti-PVRIG antibody, and COM902, an antibody targeting TIGIT, both designed for the treatment of solid tumors. Additionally, the company has early-stage programs addressing myeloid targets and various mechanisms of immune resistance. Compugen collaborates with notable partners, including Bayer Pharma AG and Bristol-Myers Squibb, to further research and develop its therapeutics. Founded in 1993, Compugen employs a hypothesis-driven approach to drug discovery, utilizing in silico methods for product candidate prediction and validation, enhancing its ability to meet unmet therapeutic needs in the pharmaceutical and biotech sectors.
Cardonet is a provider of IT support and technology services that focuses on maximizing revenue and supporting business growth. Established in 1999, the company offers a comprehensive range of managed IT services, including assistance with technical issues, server emergencies, office relocations, and data center design. Cardonet aims to enhance the buyer's experience in e-marketplaces by enabling the creation and maintenance of transactive catalogs, which can increase marketplace transactions. With a dedicated team, including active involvement from its directors, Cardonet is committed to delivering effective technology solutions that help businesses gain a competitive advantage.
HarmonyCom is a privately held, venture-backed telecommunications software solutions provider founded in 1997. It has its U.S. headquarters in Ann Arbor, Michigan with operations in London and Tel Aviv. The lead investor in HarmonyCom is Iscal Holdings, Ltd., a private Israeli investment company that focuses on emerging high-tech companies. Additional funding has been received from Yozma Venture Capital. HarmonyCom's premier product is Harmony, a software solution that automates and orchestrates the delivery of broadband data services, allowing for measurable improvements in customer satisfaction, faster time-to-market for new products, reduced operational costs, and improved accuracy of information.
Telegate is a developer of the most reliable and feature-rich VoIP system.
NextNine is a leader in Operational Technology (OT) security management software for industrial and critical infrastructure, markets that are vulnerable to cyber security attacks and are underserved by conventional enterprise IT solutions. Using NextNine you can have centralized OT security management for your entire SCADA/ICS environment. Distributed critical infrastructure plants and facilities with proprietary ICS/SCADA networks and devices, paired with the need for external vendors to provide remote maintenance and support, create an ideal target profile for hackers and terrorist attacks. Traditional IT security management solutions were designed to manage standard computing environments and cannot handle the proprietary processes, networks and devices of the ICS/SCADA world. In contrast, NextNine has over 10 years of leadership in OT security, and has purpose-built its product to deal with these unique challenges. NextNine’s solution is an industrial strength software platform delivering robust, customizable and field proven OT security management. Top tier critical infrastructure companies along with 5 of the 7 largest industrial vendors have standardized on NextNine. Today, the company has 6000 installations globally in fields such as oil, gas, mining, chemicals, energy, manufacturing, defense and critical infrastructure. NextNine has been recognized by the White House for its leadership in the efforts to improve critical infrastructure cyber security. NextNine has received ISO/IEC 27001:2013 certification, assuring NextNine's employees operate a comprehensive security program and manage information security risks effectively. NextNine's certificate is issued by the Standards Institution of Israel. The company was founded in 1998, is privately held and headquartered in New York.